Target intelligence / Profile preview

Immunoglobulin kappa variable 2-28 (IGKV2-28)

Target
IGKV2-28
Molecular classification
Other (Variable region of immunoglobulin kappa light chain)
01

Overview

Immunoglobulin kappa variable 2-28 (IGKV2-28) is the variable region of the kappa light chain of immunoglobulins (antibodies)[1][2][8]. Its primary function is to contribute to the formation of the antigen-binding site of immunoglobulins, where it participates in recognizing and binding to specific antigens, forming part of the adaptive immune response[1][2][6]. This region undergoes V-(D)-J recombination and somatic hypermutation, processes that enable the immune system to generate a vast diversity of antibody specificities[2][6]. IGKV2-28 is one of many variable region genes that encode the immunoglobulin light chain's variable domain, essential for the specificity and affinity of antigen binding[2][6]. It is not considered a therapeutic target, receptor, enzyme, or classic disease biomarker, but rather a structural component of antibodies[2][5][8].

Other names
Immunoglobulin kappa variable 2-28IGKV2-28A19IGKV228
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other (No direct disease linkage; general role in immune system diversity)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2-28 (IGKV2-28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2-28 (IGKV2-28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call